e-learning
resources
ERJ
2016
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Mast cells in asthma: biomarker and therapeutic target
Reber Laurent L., Fahy John V.
Source:
Eur Respir J 2016; 47: 1040-1042
Journal Issue:
April
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Reber Laurent L., Fahy John V.. Mast cells in asthma: biomarker and therapeutic target. Eur Respir J 2016; 47: 1040-1042
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Can YKL-40 be used as a biomarker and therapeutic target for adult asthma?
Source: Eur Respir J, 51 (1) 1702194; 10.1183/13993003.02194-2017
Year: 2018
Th17 cytokines: novel potential therapeutic targets for COPD pathogenesis and exacerbations
Source: Eur Respir J, 50 (4) 1602434; 10.1183/13993003.02434-2016
Year: 2017
Mast cells in lung disease: clinical implications
Source: International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications
Year: 2019
T-cell co-stimulatory molecules: novel targets for the treatment of allergic airway disease
Source: Eur Respir J 2007; 30: 383-390
Year: 2007
Airway inflammation in asthma: current and future targets and therapies
Source: Breathe 2010; 6: 245-252
Year: 2010
Mast cells and eosinophils: the two key effector cells in allergic inflammation
Source: Annual Congress 2010 - Mast cells and eosinophils: the two key effector cells in allergic inflammation
Year: 2010
Targeting airway inflammation in asthma: current and future therapies
Source: Annual Congress 2009 - MP7 - Targeting airway inflammation in asthma: current and future therapies
Year: 2009
Targeting airway inflammation in asthma: current and future therapies
Source: Annual Congress 2009 - PG13 Asthma: pathology and treatment
Year: 2009
Novel sub-classifications of mast cells in human lungs: differential alterations in smokers and COPD
Source: Annual Congress 2007 - Advances in respiratory mechanics
Year: 2007
Neovascularisation in asthma: Altered angiogenic potential of ASM cells from asthmatic patients
Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung
Year: 2012
TSPO a new anti-inflammatory target in the airway of COPD
Source: International Congress 2015 – Advances in the future treatment of COPD
Year: 2015
Expression of surface markers on peripheral CD4
+
CD25
high
T cells in patients with atopic asthma: role of inhaled corticosteroid
Source: Annual Congress 2008 - Risk factors for asthma versus asthma control
Year: 2008
Small airways function: evaluation in a population of adult patients with severe asthma and potential use as a response biomarker for anti-IL5 therapy
Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma
Year: 2020
Therapeutic potential of mesenchymal stem cells modified to secrete anti-inflammatory protein sST2 in a model of occupational asthma
Source: Annual Congress 2012 - Occupational asthma
Year: 2012
Mast cells in human airways: the culprit?
Source: Eur Respir Rev 2014; 23: 299-307
Year: 2014
Endothelial microparticles in sputum of COPD patients: A potential biomarker of disease
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept